CN102731584B - 一种单唾液酸四己糖神经节苷脂的制备方法 - Google Patents
一种单唾液酸四己糖神经节苷脂的制备方法 Download PDFInfo
- Publication number
- CN102731584B CN102731584B CN201210076042.4A CN201210076042A CN102731584B CN 102731584 B CN102731584 B CN 102731584B CN 201210076042 A CN201210076042 A CN 201210076042A CN 102731584 B CN102731584 B CN 102731584B
- Authority
- CN
- China
- Prior art keywords
- monostalotetrahexosylgangliside
- acetone
- volume
- concentrated solution
- brain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 95
- 238000000034 method Methods 0.000 claims abstract description 49
- 210000004556 brain Anatomy 0.000 claims abstract description 33
- 238000000605 extraction Methods 0.000 claims abstract description 32
- 230000008569 process Effects 0.000 claims abstract description 17
- 239000000843 powder Substances 0.000 claims abstract description 13
- 238000005903 acid hydrolysis reaction Methods 0.000 claims abstract description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 72
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- 238000001556 precipitation Methods 0.000 claims description 29
- 150000003408 sphingolipids Chemical class 0.000 claims description 27
- 239000007788 liquid Substances 0.000 claims description 23
- 238000007127 saponification reaction Methods 0.000 claims description 21
- 239000012043 crude product Substances 0.000 claims description 20
- 239000011347 resin Substances 0.000 claims description 18
- 229920005989 resin Polymers 0.000 claims description 18
- 239000000284 extract Substances 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 10
- 238000013016 damping Methods 0.000 claims description 10
- 239000012530 fluid Substances 0.000 claims description 10
- 239000000741 silica gel Substances 0.000 claims description 10
- 229910002027 silica gel Inorganic materials 0.000 claims description 10
- 238000001179 sorption measurement Methods 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 9
- 238000011068 loading method Methods 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 238000010898 silica gel chromatography Methods 0.000 claims description 8
- 239000002893 slag Substances 0.000 claims description 8
- 238000004587 chromatography analysis Methods 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 3
- 238000004090 dissolution Methods 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 238000004809 thin layer chromatography Methods 0.000 claims description 3
- UZUODNWWWUQRIR-UHFFFAOYSA-L disodium;3-aminonaphthalene-1,5-disulfonate Chemical compound [Na+].[Na+].C1=CC=C(S([O-])(=O)=O)C2=CC(N)=CC(S([O-])(=O)=O)=C21 UZUODNWWWUQRIR-UHFFFAOYSA-L 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 abstract description 6
- 150000002270 gangliosides Chemical class 0.000 abstract description 4
- 239000000243 solution Substances 0.000 description 26
- 239000000047 product Substances 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 239000012071 phase Substances 0.000 description 12
- 239000000523 sample Substances 0.000 description 12
- 239000000203 mixture Substances 0.000 description 10
- 239000013558 reference substance Substances 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 229960001866 silicon dioxide Drugs 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- 230000008676 import Effects 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 210000005013 brain tissue Anatomy 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 238000001819 mass spectrum Methods 0.000 description 4
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000002490 cerebral effect Effects 0.000 description 3
- 238000003795 desorption Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 238000002329 infrared spectrum Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000001291 vacuum drying Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000000274 adsorptive effect Effects 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 239000004411 aluminium Substances 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 125000005629 sialic acid group Chemical group 0.000 description 2
- 238000010183 spectrum analysis Methods 0.000 description 2
- 238000013517 stratification Methods 0.000 description 2
- -1 sulfuric acid ester Chemical class 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical class CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
- 229920002271 DEAE-Sepharose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 102000005348 Neuraminidase Human genes 0.000 description 1
- 108010006232 Neuraminidase Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000012614 Q-Sepharose Substances 0.000 description 1
- 241000364021 Tulsa Species 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000002156 adsorbate Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000001549 ceramide group Chemical group 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- VILAVOFMIJHSJA-UHFFFAOYSA-N dicarbon monoxide Chemical compound [C]=C=O VILAVOFMIJHSJA-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000010571 fourier transform-infrared absorption spectrum Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002339 glycosphingolipids Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940030980 inova Drugs 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 210000005171 mammalian brain Anatomy 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000003808 methanol extraction Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000002715 modification method Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000001225 nuclear magnetic resonance method Methods 0.000 description 1
- 230000005311 nuclear magnetism Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210076042.4A CN102731584B (zh) | 2012-03-21 | 2012-03-21 | 一种单唾液酸四己糖神经节苷脂的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210076042.4A CN102731584B (zh) | 2012-03-21 | 2012-03-21 | 一种单唾液酸四己糖神经节苷脂的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102731584A CN102731584A (zh) | 2012-10-17 |
CN102731584B true CN102731584B (zh) | 2015-04-22 |
Family
ID=46987958
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210076042.4A Active CN102731584B (zh) | 2012-03-21 | 2012-03-21 | 一种单唾液酸四己糖神经节苷脂的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102731584B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104151372B (zh) * | 2014-07-30 | 2017-05-17 | 湖南利诺生物药业有限公司 | 单唾液酸四已糖神经节苷脂gm1原料的制备方法 |
CN106905387A (zh) * | 2017-03-20 | 2017-06-30 | 泸州瑞兴生物工程有限公司 | 一种单唾液酸四己糖神经节苷脂钠的制备方法 |
CN114965822A (zh) * | 2017-10-27 | 2022-08-30 | 齐鲁制药有限公司 | 高效测定神经节苷脂gm1及其杂质的药物分析方法 |
CN108822164A (zh) * | 2018-05-23 | 2018-11-16 | 海南益尔生物制药有限公司 | 高质量单唾液酸四己糖神经节苷脂钠的制备工艺 |
CN108546276A (zh) * | 2018-05-23 | 2018-09-18 | 海南益尔生物制药有限公司 | 一种快速高效制备高纯度神经节苷脂的方法 |
CN109705176A (zh) * | 2019-01-23 | 2019-05-03 | 苏州纳微科技股份有限公司 | 一种猪神经节苷脂的分离纯化方法 |
CN109651458A (zh) * | 2019-01-31 | 2019-04-19 | 定安益尔生物技术有限公司 | 高效水解转化制备神经节苷脂的方法 |
CN110592164A (zh) * | 2019-09-23 | 2019-12-20 | 东北师范大学 | 一种单唾液酸四己糖神经节苷脂的制备方法 |
CN111499671A (zh) * | 2020-04-14 | 2020-08-07 | 内蒙古自治区中医药研究所 | 羊脑中几种不同类型神经节苷脂的提取制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1400216A (zh) * | 2001-07-26 | 2003-03-05 | 上海绿谷伟业生态工程有限公司 | 一种从动物组织中提取神经节苷脂的方法 |
CN101108868A (zh) * | 2007-07-12 | 2008-01-23 | 四川阳光博睿生物技术有限公司 | 制备高纯度单唾液酸四己糖神经节苷脂的方法 |
-
2012
- 2012-03-21 CN CN201210076042.4A patent/CN102731584B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1400216A (zh) * | 2001-07-26 | 2003-03-05 | 上海绿谷伟业生态工程有限公司 | 一种从动物组织中提取神经节苷脂的方法 |
CN101108868A (zh) * | 2007-07-12 | 2008-01-23 | 四川阳光博睿生物技术有限公司 | 制备高纯度单唾液酸四己糖神经节苷脂的方法 |
Non-Patent Citations (1)
Title |
---|
Utilization of Ganglioside-Degrading Paenibacillus sp. Strain TS12 for Production of Glucosylceramide;Tomomi Sumida et al;《APPLIED AND ENVIRONMENTAL MICROBIOLOGY》;20021130;第68卷(第11期);5241–5248 * |
Also Published As
Publication number | Publication date |
---|---|
CN102731584A (zh) | 2012-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102731584B (zh) | 一种单唾液酸四己糖神经节苷脂的制备方法 | |
CN102775523B (zh) | 一种制备高纯度低分子肝素钠的工艺 | |
CN101619028B (zh) | 一种制备辣椒碱单体的方法 | |
CN1321961C (zh) | 一种从虎杖中提取纯化白藜芦醇的新方法 | |
CN103130876B (zh) | 一种高纯度多粘菌素b的制备方法 | |
CN108864217B (zh) | 一种石榴皮安石榴苷的纯化方法 | |
CN101177439B (zh) | 千克级规模高纯度单唾液酸四己糖神经节苷脂的制备 | |
CN102040610A (zh) | 一种利用机械化学原理同时从茶叶中提取咖啡因、茶多酚和茶多糖的新方法 | |
Li et al. | Thioether bridged cationic cyclodextrin stationary phases: Effect of spacer length, selector concentration and rim functionalities on the enantioseparation | |
CN102875450B (zh) | 一种从桑叶中提取制备1-脱氧野尻霉素的工艺方法 | |
CN101322758B (zh) | 利用复合酶生产酸枣仁提取物的方法 | |
CN101074188B (zh) | 利用大孔吸附树脂富集纯化花生根中白藜芦醇的方法 | |
CN103058871B (zh) | 一种烟草绿原酸的分离纯化方法 | |
CN101260138B (zh) | 一种远志酸和远志皂苷元的高效分离提纯方法 | |
TWI648253B (zh) | 純化奇壬醇的方法 | |
CN109942663B (zh) | 利用双相酸水解制备环黄芪醇的方法 | |
CN1765917A (zh) | 人参皂苷Rb2的制备工艺 | |
CN104788509B (zh) | 一种从脱脂麦胚中提取制备高纯度棉子糖的工艺 | |
CN104059117B (zh) | 一种从刺糖多孢菌发酵液中提取多杀菌素的方法 | |
CN105348336B (zh) | 一种从白柳皮中制备水杨苷的方法 | |
CN110592164A (zh) | 一种单唾液酸四己糖神经节苷脂的制备方法 | |
CN1513869A (zh) | 丙二酰基人参皂苷结构修饰、富集人参皂苷Rb1工艺 | |
CN102020682B (zh) | 一种诃黎勒鞣花酸的制备方法 | |
CN110003287A (zh) | 一种快速高效制备总神经节苷脂的方法 | |
CN110240544A (zh) | 一种绿原酸提取纯化方法及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20151123 Address after: 646100 Lily Town, Luzhou, Sichuan, Luxian County Patentee after: Luzhou Ruixing Biological Engineering Co. Ltd. Address before: 646100 Lily Town, Luzhou, Sichuan, Luxian County Patentee before: Luzhou Ruixing Chemical Industry Co., Ltd. Patentee before: Chongqing Zihe Pharmaceutical Technology Development Co., Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of monosialoteterahexosylganglioside Effective date of registration: 20180828 Granted publication date: 20150422 Pledgee: Luzhou Xinglu finance Company limited by guarantee Pledgor: Luzhou Ruixing Biological Engineering Co. Ltd. Registration number: 2018510000087 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190819 Granted publication date: 20150422 Pledgee: Luzhou Xinglu finance Company limited by guarantee Pledgor: Luzhou Ruixing Biological Engineering Co. Ltd. Registration number: 2018510000087 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of monosialoteterahexosylganglioside Effective date of registration: 20190827 Granted publication date: 20150422 Pledgee: Luzhou Xinglu Financing Guarantee Group Co., Ltd. Pledgor: Luzhou Ruixing Biological Engineering Co. Ltd. Registration number: Y2019510000013 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of monosialoteterahexosylganglioside Effective date of registration: 20190827 Granted publication date: 20150422 Pledgee: Luzhou Xinglu Financing Guarantee Group Co., Ltd. Pledgor: Luzhou Ruixing Biological Engineering Co. Ltd. Registration number: Y2019510000013 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200903 Granted publication date: 20150422 Pledgee: Luzhou Xinglu Financing Guarantee Group Co.,Ltd. Pledgor: LUZHOU RUIXING BIOENGINEERING Co.,Ltd. Registration number: Y2019510000013 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210407 Address after: 646100 Lingang Economic Park, Luxian Economic Development Zone, Luzhou City, Sichuan Province Patentee after: SICHUAN QIGEMAN PHARMACEUTICAL Co.,Ltd. Address before: 646100 Baihe Town, Luxian County, Luzhou City, Sichuan Province Patentee before: LUZHOU RUIXING BIOENGINEERING Co.,Ltd. |